RAYMOND JAMES & ASSOCIATES - NUVATION BIO INC ownership

NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 121 filers reported holding NUVATION BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of NUVATION BIO INC
ValueSharesWeighting
Q3 2023$19,711
-38.2%
14,710
-16.9%
0.00%
Q2 2023$31,878
-11.1%
17,710
-18.0%
0.00%
Q1 2023$35,873
-11.1%
21,610
+2.9%
0.00%
Q4 2022$40,339
-16.0%
21,010
-1.6%
0.00%
Q3 2022$48,000
-30.4%
21,3600.0%0.00%
Q2 2022$69,000
-17.9%
21,360
+33.0%
0.00%
Q1 2022$84,000
-20.8%
16,060
+28.9%
0.00%
Q4 2021$106,000
-7.0%
12,460
+8.7%
0.00%
Q3 2021$114,000
+11.8%
11,460
+4.6%
0.00%
Q2 2021$102,00010,9600.00%
Other shareholders
NUVATION BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
Omega Fund Management, LLC 15,072,340$28,938,8939.75%
Aisling Capital Management LP 2,541,009$4,878,7373.22%
EDBI Pte Ltd 1,270,504$2,439,3683.11%
EcoR1 Capital, LLC 13,896,543$26,681,3630.81%
Deep Track Capital, LP 8,221,188$15,784,6810.66%
AlphaCentric Advisors LLC 325,000$624,0000.62%
683 Capital Management, LLC 2,500,000$4,799,9990.41%
BRAIDWELL LP 4,122,900$7,915,9680.26%
Abrams Capital Management 3,811,513$7,318,1050.26%
Redmile Group, LLC 3,031,009$5,819,5370.24%
View complete list of NUVATION BIO INC shareholders